EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19

Ji Qiu iD, Anna Engelbrektson, Lusheng Song, Jin Park, Vel Murugan, Stacy Williams, Yunro Chung, Ericka Nelly Pompa-Mera, Jorge Luis Sandoval-Ramirez, Jose Antonio Mata-Marin, Jesus Gaytan-Martinez, Eliana Troiani und 6 weitere

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.04690-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Ji Qiu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA. Hauptthemen laut MEDLINE: COVID-19, Coronavirus 229E, Human, Coronavirus OC43, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Consejo Nacional de Ciencia y Tecnología, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical presentations of COVID-19 range from asymptomatic to critical illness that may lead to intensive care or even death. The health of the immune system, as partially shaped by past infections or vaccinations, is critical to control and resolve the infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Coronavirus 229E, HumanCoronavirus OC43, HumanHumansSARS-CoV-2Antibodies, Viral

Stichwörter der Autor:innen

COVID-19SARS-CoV-2antibody profilingherpesvirushuman coronavirusprotein arraysrespiratory virusvirus antibody

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
  • College of Health Solutions, Arizona State University, Phoenix, Arizona, USA.
  • Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, UMAE Hospital de Pediatría, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Hospital de Infectología, CMN "La Raza", Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Università Cattolica del Sacro Cuore, Rome, Italy.
  • Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

ORCID-Profile: Ji Qiu, Javier Torres

Förderung

  • NCI NIH HHS
  • Consejo Nacional de Ciencia y Tecnología
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Qiu, J., Engelbrektson, A., Song, L., Park, J., Murugan, V., Williams, S., Chung, Y., Pompa-Mera, E. N., Sandoval-Ramirez, J. L., Mata-Marin, J. A., Gaytan-Martinez, J., Troiani, E., Sanguinetti, M., Roncada, P., Urbani, A., Moretti, G., Torres, J., & LaBaer, J. (2023). Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04690-22

Vancouver

Qiu J, Engelbrektson A, Song L, Park J, Murugan V, Williams S, et al. Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19. Microbiology Spectrum. 2023. doi:10.1128/spectrum.04690-22

BibTeX
@article{Qiu2023,
  author = {Qiu, Ji and Engelbrektson, Anna and Song, Lusheng and Park, Jin and Murugan, Vel and Williams, Stacy and Chung, Yunro and Pompa-Mera, Ericka Nelly and Sandoval-Ramirez, Jorge Luis and Mata-Marin, Jose Antonio and Gaytan-Martinez, Jesus and Troiani, Eliana and Sanguinetti, Maurizio and Roncada, Paola and Urbani, Andrea and Moretti, Giacomo and Torres, Javier and LaBaer, Joshua},
  title = {Comparative Analysis of Antimicrobial Antibodies between Mild and Severe COVID-19},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.04690-22}
}
Kostenlos starten →